sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER]

4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER]

CAS No.:
27470-51-5
Catalog Number:
AG00BF6I
Molecular Formula:
C24H26N2O6
Molecular Weight:
438.4730
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
10mg
99%
1 week
United States
$140
- +
Product Description
Catalog Number:
AG00BF6I
Chemical Name:
4-BUTYL-4-[HYDROXYMETHYL]-1,2-DIPHENYL-3,5-PYRAZOLIDINEDIONE HYDROGEN SUCCINATE [ESTER]
CAS Number:
27470-51-5
Molecular Formula:
C24H26N2O6
Molecular Weight:
438.4730
MDL Number:
MFCD00079562
IUPAC Name:
4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid
InChI:
InChI=1S/C24H26N2O6/c1-2-3-16-24(17-32-21(29)15-14-20(27)28)22(30)25(18-10-6-4-7-11-18)26(23(24)31)19-12-8-5-9-13-19/h4-13H,2-3,14-17H2,1H3,(H,27,28)
InChI Key:
ONWXNHPOAGOMTG-UHFFFAOYSA-N
SMILES:
CCCCC1(COC(=O)CCC(=O)O)C(=O)N(N(C1=O)c1ccccc1)c1ccccc1
EC Number:
248-477-6
UNII:
86TDZ5WP2B
NSC Number:
757866
Properties
Complexity:
661  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
438.179g/mol
Formal Charge:
0
Heavy Atom Count:
32  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
438.48g/mol
Monoisotopic Mass:
438.179g/mol
Rotatable Bond Count:
11  
Topological Polar Surface Area:
104A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.6  
Literature
Title Journal
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Antemortem diagnosis of a distal axonopathy causing severe stringhalt in a horse. Journal of veterinary internal medicine 20100101
Rapid confirmatory analysis of non-steroidal anti-inflammatory drugs in bovine milk by rapid resolution liquid chromatography tandem mass spectrometry. Journal of chromatography. A 20091113
Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses. Equine veterinary journal 20090901
Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses. Veterinary therapeutics : research in applied veterinary medicine 20090101
Evaluation of the palatability of three nonsteroidal antiinflammatory top-dress formulations in horses. Veterinary therapeutics : research in applied veterinary medicine 20080101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. Research in veterinary science 20040401
Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation. Journal of analytical toxicology 20010101
Diagnosis of antibody-mediated drug allergy. Pyrazolinone and pyrazolidinedione cross-reactivity relationships. Allergy 19871101
Promotion of hepatocarcinogenesis by suxibuzone in rats initiated with 3'-methyl-4-dimethylaminoazobenzene. Cancer letters 19870701
Properties